Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:APTO

Aptose Biosciences (APTO) Stock Price, News & Analysis

Aptose Biosciences logo

About Aptose Biosciences Stock (NASDAQ:APTO)

Key Stats

Today's Range
N/A
50-Day Range
$1.71
$6.86
52-Week Range
N/A
Volume
650,294 shs
Average Volume
227,964 shs
Market Capitalization
$3.66 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Consensus Rating
Strong Buy

Company Overview

Receive APTO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aptose Biosciences and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

APTO Stock News Headlines

Buy this stock before Tesla’s November 6 announcement
The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff, as the world's biggest car firm prepares to launch a "mind blowing" new product. It has nothing to do with EVs, or self-driving cars. In fact, it's not a car at all...tc pixel
Aptose Biosciences Inc News (APS) - Investing.com
See More Headlines

APTO Stock Analysis - Frequently Asked Questions

Aptose Biosciences Inc. (NASDAQ:APTO) announced its earnings results on Thursday, August, 8th. The biotechnology company reported ($12.90) earnings per share for the quarter, beating the consensus estimate of ($17.40) by $4.50.

Aptose Biosciences's stock reverse split before market open on Wednesday, February 26th 2025.The 1-30 reverse split was announced on Tuesday, February 18th 2025. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, February 25th 2025. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aptose Biosciences investors own include Digital Turbine (APPS), Okta (OKTA), Canoo (GOEV), CrowdStrike (CRWD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/08/2024
Today
10/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:APTO
CIK
882361
Employees
31
Year Founded
2014

Price Target and Rating

High Price Target
$6.00
Low Price Target
$6.00
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($89.19)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$51.21 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-5,683.22%
Return on Assets
-300.44%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.05
Quick Ratio
1.05

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.19) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
2,141,000
Free Float
63,446,000
Market Cap
$3.66 million
Optionable
No Data
Beta
1.04

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:APTO) was last updated on 10/14/2025 by MarketBeat.com Staff
From Our Partners